About Michael J Haller
Dr. Haller is Professor and Chief of Pediatric Endocrinology at the University of Florida. He has been involved in type 1 diabetes research since the early 1990s and has published over 200 manuscripts and more than 20 reviews/book chapters on type 1 diabetes pathogenesis, prevention, and interdiction. He is the principal investigator or co-investigator on numerous JDRF, NIH, and Helmsley trust funded studies.
Pediatric EndocrinologyAmerican Board of Pediatrics
PediatricsAmerican Board of Pediatrics
- Pediatric Endocrinology
- Pediatric pituitary and skull base services
- Type 1 diabetes
Dr. Haller’s research focuses on predicting, preventing, and ultimately reversing type 1 diabetes through his participation in numerous clinical trials utilizing immunotherapies. Dr. Haller serves as the Principal Investigator for the University of Florida TrialNet Clinical Center, Chair of the TEDDY Clinical Implementation Committee, and PI of the UF/Stanford ECHO Collaborative. Dr. Haller also leads and participates in technology studies seeking to improve the lives of people living with diabetes through the use of pumps, continuous glucose monitors, and systems that automate insulin delivery.
- Prevention and intervention trials in Type 1 diabetes
- Type 1 Diabetes Treatment